Positron emission tomography for neurologists

Area of Science:

• Neurology
• Nuclear Medicine
• Medical Imaging

Background:

• Fluorodeoxyglucose Positron Emission Tomography (FDG PET) is a functional brain imaging technique.
• Neurologists can utilize FDG PET in clinical practice for patient management.
• Reimbursement for FDG PET is often based on specific neurological indications.

Purpose of the Study:

• To review the current clinical applications of FDG PET in neurology.
• To inform practicing neurologists about the utility of FDG PET in patient care.
• To emphasize the value of FDG PET in managing various neurological conditions.

Main Methods:

• Literature review of current clinical applications of FDG PET in neurology.
• Focus on practical, present-day uses for practicing neurologists.
• Examination of indications across different disease states.

Main Results:

• FDG PET has established indications in dementia, neuro-oncology, and epilepsy.
• Applications extend to parkinsonism and other less common neurological disorders.
• FDG PET provides unique functional brain insights.

Conclusions:

• FDG PET offers valuable, often unique, information for neurological patient management.
• Its application facilitates more rational and cost-effective healthcare decisions.
• The use of FDG PET benefits patients, referring physicians, and the healthcare system.